Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Lablytica Life Science AB
AB
Active
Org 5592179088
Virdings Allé 16, 754 50
Uppsala
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2019
11 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Lablytica Life Science AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
DF
David Fessenden Pekar
Chief Executive Officer
Chief Executive Officer
2020
SA
Stéphanie Anna Chantal Ljungberg
Chief Auditor
Chief Auditor
2020
Former (1)
MP
Mats Peter Lindquist
Chief Executive Officer
Chief Executive Officer
2020 – 2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
WJ
Willem Jan Tamminga
Board of Directors
2026
KJ
Karin Judith Meyer
Chairman
2022
BF
Bror Folke Sjöberg
Deputy Board Member
2022
Former (2)
BE
Bengt Erik Dahlström
Chairman
2020 – 2022
AM
Anders Millerhovf
Deputy Board Member
2020 – 2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Center for Translational Research Sweden AB
Company
91%
91%
0001
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Lablytica Life Science AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network